Bonti

Bonti

Bonti

Bonti is a rapidly emerging biotech company. Our lead product candidate is EB001, is used for both Therapeutic & Aesthetic needs.
Type
B2c
Founded
2015
Raised
$27.2M
Follow us
Alexa global traffic share
Latest funding
$15,500,000
Venture capital (Series C) - 2018
$11,700,000
Venture capital (Series B) - 2017
City Hill Ventures Colt Ventures RBV Capital
Team Size
2
Employees
AVCJ

China's HighLight to exit US-based biotech player Bonti

$15,500,000 Venture capital (Series C)
VentureWire , PE HUB

Former Botox Bosses Raise $15.5 Million for Biotech Startup Bonti

FinSMEs

Bonti Closes $15.5M Series C Funding

Funding Health
$11,700,000 Venture capital (Series B)
businesswire

Bonti Raises $11.7 Million in an Oversubscribed Series B Financing to Advance Development of Lead Product EB-001